MedPath

Estradiol

Estradiol Tablets USP

Approved
Approval ID

8f8c5a0b-4d7b-a5cb-e053-2995a90a494e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 9, 2022

Manufacturers
FDA

PharmPak, Inc.

DUNS: 175493840

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ESTRADIOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54348-702
Application NumberANDA040197
Product Classification
M
Marketing Category
C73584
G
Generic Name
ESTRADIOL
Product Specifications
Route of AdministrationORAL
Effective DateOctober 9, 2022
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ESTRADIOLActive
Quantity: 2 mg in 1 1
Code: 4TI98Z838E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Estradiol - FDA Drug Approval Details